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Objectives: Medicaid expansion under the Patient Protection and Affordable Care 
Act (ACA) will add new enrollees to Medicaid programs in states that elect to expand 
eligibility. The objective of this study is to provide projections of inpatient hospital and 
emergency department (ED) use after ACA Medicaid expansion. MethOds: Hospital 
Inpatient and ED records were extracted from Healthcare Cost and Utilization Project 
State Inpatient Databases for the years 2007–2011and State Emergency Department 
Databases for the years 2007–2010. The enrollment estimates were based on the 
Centers for Medicare & Medicaid Services Medicaid statistics and information from 
the American Community Surveys for 2007–2011. Inpatient discharge records were 
aggregated by the state of the patient’s residence, year, and major service lines includ-
ing Medicine, Surgery, Maternity & Newborn, Injuries and Mental Health. Data were 
restricted to adults aged 19–64 years, because this age group is likely to contribute 
the vast majority of new Medicaid enrollees. Regression models estimated utiliza-
tion measures from predictor variables. Hospital utilization metrics were total dis-
charges, preventable admissions, and emergency department visits. Discharge and 
ED visit rates were estimated using the state- and year-specific Medicaid enrollment 
estimates. Data for Medicaid patients were aggregated by state, year, and type of 
service. Results: Our models project that change in population composition alone 
results in a 22% increase in inpatient discharges and a 30% increase in ED visits, while 
use rates fall 6% and 0%, respectively. With the additional capacity, reimbursement, 
and innovation policy effects in place, inpatient discharges increase by 7% and ED 
visits by only 1%, while use rates fall 18% and 22%. cOnclusiOns: Medicaid expan-
sion will increase inpatient and ED volumes, but utilization rates will be below current 
levels. States can limit increases through provider capacity, Medicaid managed care, 
and increasing physician acceptance of Medicaid patients.
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Objectives: In 2014, many states will initiate Medicaid expansion under the 
Affordable Care Act; some states will not. Medicaid expansion is expected to 
increase hospital utilization as previously uninsured adults become covered under 
Medicaid. Our objective is to define benchmarks for the rates of hospital inpatient 
and emergency department (ED) use following Medicaid expansion. MethOds: We 
obtained hospital use data from the Healthcare Cost and Utilization Project 2010 
State Inpatient Databases and State Emergency Department Databases. We obtained 
state-level data on Medicaid program characteristics and population demographics 
and health status from Centers for Medicare & Medicaid Services Medicaid statis-
tics, American Community Survey, and Behavioral Risk Factor Surveillance Survey. 
We examined whether hospital utilization rates differed based on states’ stance 
on Medicaid expansion. We standardized the hospital use metrics by computing 
separate index values for the Medicaid and uninsured population metrics relative 
to the national mean so that all measures had similar scale. We then examined 
which state-level Medicaid program, demographic, and health status characteristics 
were related to the states’ expansion stance. Results: We found that several state 
health system infrastructure characteristics were strongly related to both expan-
sion likelihood and hospital utilization. In particular, in states highly likely to adopt 
Medicaid expansion in 2014, we observed higher levels of Medicaid managed care 
organization penetration, a lower primary care physician supply challenge, a lower 
level of primary care case management, and a smaller expansion population size 
relative to the current Medicaid population. We also found that in those states that 
are currently committed to Medicaid expansion had substantially lower hospital 
inpatient and ED use among Medicaid-covered patients compared to states that 
have not committed to expand. cOnclusiOns: Our results revealed a lower impact 
of Medicaid expansion on hospital utilization among states that have elected to 
expand than among states currently unlikely to expand.
abstRacts
ah3
adjusting budget imPact model based on new changes due to 
affoRdable caRe act
Aggarwal S., Topaloglu H., Kumar S.
Novel Health Strategies, Bethesda, MD, USA
Objectives: The Affordable Care Act (ACA) has introduced several major changes, 
which can impact product pricing, access and uptake in the United States. The 
objective of this analysis was to review all major new changes due to ACA and 
develop a target list of adjustments for budget impact model (BIM) for US pay-
ers. MethOds: The new pricing, access and coverage changes impacting the 
pharmaceutical and devices products were reviewed using the bill for ACA (H. R. 
3590), 2011-2013 policy publications, reports by Congressional Budget Office and 
Government Accountability Office, and the latest Centers for Medicare & Medicaid 
Services (CMS) guidelines for Essential Health Benefits (EHBs). Primary discussions 
with US private payers and ex-CMS policy experts were conducted to understand 
key issues for medical products. A US budget impact model was adjusted to illus-
trate the type of changes and their impact on model results. Results: The ACA 
has introduced major changes for product pricing, deductible, coverage and uptake. 
For pricing, two model adjustments are 50% discount for Part D population and 
increased rebate of 23.1% for Medicaid population. For deductible, the patient costs 
are capped at $12,700. For uptake, an additional population is eligible based on 
expanded access to 30 million uninsured Americans, with more than half of them 
being under the age of 35 years (~59%). For access, the 2014 definition of Essential 
Drug Benefits is likely to either expand or reduce coverage depending upon the 
State and class of drugs. For example, for NSAIDs in CA only 20 drugs, while in NY, 
40 drugs are covered. Scenario analysis shows -10 % to +15% impact on total budget 
impact. cOnclusiOns: Budget impact models in the US need to be adjusted based 
on the new changes introduced by the ACA.
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Objectives: This study aimed to examine and forecast the racial/ethnic dispar-
ity of eye examination rates among US adults with diabetes before and after the 
ACA. MethOds: Working-age adults (18-64 years) with diabetes were extracted 
from the Medical Expenditure Panel Survey Household Component 2011. For the 
years 2014 to 2017 after the ACA, samples were simulated from the 2011 population 
using the bootstrap method. Insurance coverage rates were separately predicted 
for each racial/ethnic group based on the Congressional Budgeting Office report 
and the proportions of diabetes patients potentially qualified for Medicaid under 
the ACA. Racial/ethnic groups were dichotomized as non-Hispanic whites (NHW) 
and minorities. Eye examination was defined as reporting ≥ 1 dilated eye examina-
tions. Eye examination rates were weighted to national estimates and compared 
between racial/ethnic groups for each year. Confidence intervals were collected 
using the percentile bootstrap method. Results: After the ACA implementation, 
health insurance coverage is forecasted to increase from 90% in 2011 to 98% in 
2014 among NHW and reach 99% in 2017. The minorities are forecasted to have a 
15% expansion of insurance coverage from 2011 (81%) to 2014 (96%), and slightly 
grow to 98% in 2017. In 2011, 63% of NHW had eye examinations and forecast an 
increase to 66% in 2014 and 66% in 2017. While the eye examination rate among 
the minority population will increase from 56% in 2011 to 59% in 2014, and remain 
at 59% in 2017. The racial/ethnic differences in eye examination are forecasted to 
persist (ranging from 6.25% in 2016 to 6.54% in 2015). cOnclusiOns: The ACA is 
projected to reduce disparity in health insurance coverage by larger expansion of 
health insurance for minority populations than for their white counterparts. The 
racial/ethnic differences in eye examinations for patients with diabetes existed 
before ACA and are forecasted to persist after the ACA.
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